Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Falk

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|June 26, 1997
Restrictive cardiomyopathyJ Reisinger, S W Dubrey, R H Falk
Cardiovascular Research|March 1, 1981
Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonistR H Falk, R D Desilva, B Lown
Chest|March 14, 1998
Generic warfarin: a cost-effective alternative to brand-name drug or a clinical wild card?J M DeCara, S Croze, R H Falk
American Heart Journal|January 1, 1992
Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up studyR H Falk, E Foster, M H Coats
Journal of the American College of Cardiology|January 1, 1984
Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalitiesR H Falk, A Rubinow, A S Cohen
British Heart Journal|January 1, 1979
Prosthetic valve endocarditis resulting from Nocardia asteroidesR H Falk, F R Dimock, J Sharkey
The New England Journal of Medicine|March 10, 1988
Verapamil-induced atrial fibrillationR H Falk, A A Knowlton, S Manaker
American Heart Journal|June 1, 1982
Electrical-induced sustained myocardial depolarization as a possible cause for transient ST elevation post-DC elective cardioversionA B Zelinger, R H Falk, W B Hood
Lancet (London, England)|April 16, 1977
Mental distress in patient on disopyramideR H Falk, P A Nisbet, T J Gray
Archives of Internal Medicine|August 13, 1998
Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillationM H Eckman, R H Falk, S G Pauker
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|June 26, 1997
Restrictive cardiomyopathyJ Reisinger, S W Dubrey, R H Falk
Cardiovascular Research|March 1, 1981
Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonistR H Falk, R D Desilva, B Lown
Chest|March 14, 1998
Generic warfarin: a cost-effective alternative to brand-name drug or a clinical wild card?J M DeCara, S Croze, R H Falk
American Heart Journal|January 1, 1992
Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up studyR H Falk, E Foster, M H Coats
Journal of the American College of Cardiology|January 1, 1984
Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalitiesR H Falk, A Rubinow, A S Cohen
British Heart Journal|January 1, 1979
Prosthetic valve endocarditis resulting from Nocardia asteroidesR H Falk, F R Dimock, J Sharkey
The New England Journal of Medicine|March 10, 1988
Verapamil-induced atrial fibrillationR H Falk, A A Knowlton, S Manaker
American Heart Journal|June 1, 1982
Electrical-induced sustained myocardial depolarization as a possible cause for transient ST elevation post-DC elective cardioversionA B Zelinger, R H Falk, W B Hood
Lancet (London, England)|April 16, 1977
Mental distress in patient on disopyramideR H Falk, P A Nisbet, T J Gray
Archives of Internal Medicine|August 13, 1998
Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillationM H Eckman, R H Falk, S G Pauker
Pageof 12